semaglutide diabetes ozempic (semaglutide) for the Treatment of Type 2 Popular diabetes and weight-loss drug

Donna Ryan reports personal honoraria from Nestl Health Science for expert panel meetings related to project

GLP-1 agonists have increased myelination, delayed clinical manifestations, and improved symptoms as a neuroprotective agent

In the context of ovarian cancer, Cutter et al

Chat with your doctor about what tests make sense for you and how often you should be getting them done

He added that Novo Nordisks GLP-1 portfolio is backed by more than 50 robust clinical trials, 49 million patient-years of exposure, extensive real-world data, world-class rDNA manufacturing processes, state-of-the-art devices and delivery systems, and the highest safety standards. In 2025, the World Health Organization added semaglutide to its Essential Medicines List, recognising its critical role in tackling the global health burden

It works by mimicking the action of two hormones, GLP-1 and GIP, which affect appetite, digestion, and glucose regulation